CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Fenfluramine

氟苯丙胺 杂质对照品Fenfluramine Impurities

39 个杂质条目39 impurity entries

本页汇总 氟苯丙胺 的 39 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 39 impurity reference standards of Fenfluramine. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 氟苯丙胺(Fenfluramine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studies[Determination of chlorphentermine, fenfluramine and related substances in urine]
    Arzneimittel-Forschung · 1967 · Weischer ML, Opitz K  ·  PMID 5631594
  2. 分析方法Analytical MethodsIdentification of fenfluramine adulteration in slimming foods using a highly sensitive immunoassay
    Talanta · 2025 · Pan K et al.  ·  PMID 39406101  ·  DOI
  3. 分析方法Analytical Methods[Determination of fenfluramine hydrochloride in tablets by gas chromatography with derivatization]
    Se pu = Chinese journal of chromatography · 2001 · Tao QF  ·  PMID 12541816

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisA mechanism by which fenfluramine and benfluorex could inhibit the synthesis of triacylglycerols [proceedings]
    British journal of pharmacology · 1978 · Brindley DN et al.  ·  PMID 719236
  • 合成方法SynthesisEffects of fenfluramine and related compounds on the synthesis of glycerolipids by rat liver
    Postgraduate medical journal · 1975 · Brindley DN, Bowley M  ·  PMID 176641

氟苯丙胺 —— 原料药与杂质对照品Fenfluramine — drug substance & impurities

共 39 个条目(含原料药本体)39 items incl. the drug substance
Fenfluramine Impurity 1 structure
1
氟苯丙胺杂质1Fenfluramine Impurity 1
Fenfluramine Impurity 1
CAS No.52777-74-9
Chemical FormulaC13H18F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 3 structure
3
氟苯丙胺杂质3Fenfluramine Impurity 3
Fenfluramine Impurity 3
CAS No.37577-24-5
Chemical FormulaC12H16F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 4 (Norfenfluramine) structure
4
氟苯丙胺杂质4(去乙芬氟拉明)Fenfluramine Impurity 4 (Norfenfluramine)
Fenfluramine Impurity 4 (Norfenfluramine)
CAS No.1886-26-6
Chemical FormulaC10H12F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 5 structure
5
氟苯丙胺杂质5Fenfluramine Impurity 5
Fenfluramine Impurity 5
CAS No.37577-22-3
Chemical FormulaC10H12F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 5 Hydrochloride structure
5
氟苯丙胺杂质5 盐酸盐Fenfluramine Impurity 5 Hydrochloride
Fenfluramine Impurity 5 Hydrochloride
CAS No.41538-52-7
Chemical FormulaC10H12F3N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 6 Hydrochloride structure
6
氟苯丙胺杂质6 盐酸盐Fenfluramine Impurity 6 Hydrochloride
Fenfluramine Impurity 6 Hydrochloride
CAS No.37936-89-3
Chemical FormulaC10H12F3N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 7 structure
7
氟苯丙胺杂质7Fenfluramine Impurity 7
Fenfluramine Impurity 7
CAS No.21235-67-6
Chemical FormulaC10H9F3O
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 8 structure
8
氟苯丙胺杂质8Fenfluramine Impurity 8
Fenfluramine Impurity 8
CAS No.713-45-1
Chemical FormulaC10H9F3O
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 9 structure
9
氟苯丙胺杂质9Fenfluramine Impurity 9
Fenfluramine Impurity 9
CAS No.172953-70-7
Chemical FormulaC12H16F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 10 Monomer structure
10
氟苯丙胺杂质10 单体Fenfluramine Impurity 10 Monomer
Fenfluramine Impurity 10 Monomer
CAS No.1683-15-4
Chemical FormulaC12H16F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 10 structure
10
氟苯丙胺杂质10Fenfluramine Impurity 10
Fenfluramine Impurity 10
CAS No.54779-55-4
Chemical FormulaC12H16F3N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 11 structure
11
氟苯丙胺杂质11Fenfluramine Impurity 11
Fenfluramine Impurity 11
CAS No.2518301-21-6
Chemical FormulaC14H20F3N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 11 Monomer structure
11
氟苯丙胺杂质11 单体Fenfluramine Impurity 11 Monomer
Fenfluramine Impurity 11 Monomer
CAS No.74051-11-9
Chemical FormulaC14H20F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 12 structure
12
氟苯丙胺杂质12Fenfluramine Impurity 12
Fenfluramine Impurity 12
CAS No.21906-39-8
Chemical FormulaC10H9F3O
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 13 structure
13
氟苯丙胺杂质13Fenfluramine Impurity 13
Fenfluramine Impurity 13
CAS No.621-45-4
Chemical FormulaC10H11F3O
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 15 (N-Nitroso Fenfluramine) structure
15
氟苯丙胺杂质15 (N-亚硝基氟苯丙胺)Fenfluramine Impurity 15 (N-Nitroso Fenfluramine)
Fenfluramine Impurity 15 (N-Nitroso Fenfluramine)
CAS No.19023-40-6
Chemical FormulaC12H15F3N2O
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 18 structure
18
氟苯丙胺杂质18Fenfluramine Impurity 18
Fenfluramine Impurity 18
CAS No.401-78-5
Chemical FormulaC7H4BrF3
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 19 structure
19
氟苯丙胺杂质19Fenfluramine Impurity 19
Fenfluramine Impurity 19
CAS No.1997-28-0
Chemical FormulaC14H15F3O4
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 20 structure
20
氟苯丙胺杂质20Fenfluramine Impurity 20
Fenfluramine Impurity 20
CAS No.144758-28-1
Chemical FormulaC10H7F3O4
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 21 structure
21
氟苯丙胺杂质21Fenfluramine Impurity 21
Fenfluramine Impurity 21
CAS No.3038-48-0
Chemical FormulaC9H7F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 22 structure
22
氟苯丙胺杂质22Fenfluramine Impurity 22
Fenfluramine Impurity 22
CAS No.32857-62-8
Chemical FormulaC9H7F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 23 structure
23
氟苯丙胺杂质23Fenfluramine Impurity 23
Fenfluramine Impurity 23
CAS No.351-35-9
Chemical FormulaC9H7F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 24 structure
24
氟苯丙胺杂质24Fenfluramine Impurity 24
Fenfluramine Impurity 24
CAS No.2967-66-0
Chemical FormulaC9H7F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 28 structure
28
氟苯丙胺杂质28Fenfluramine Impurity 28
Fenfluramine Impurity 28
CAS No.54779-69-0
Chemical FormulaC12H16F3NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 29 structure
29
氟苯丙胺杂质29Fenfluramine Impurity 29
Fenfluramine Impurity 29
CAS No.2338-76-3
Chemical FormulaC9H6F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 30 structure
30
氟苯丙胺杂质30Fenfluramine Impurity 30
Fenfluramine Impurity 30
CAS No.3038-47-9
Chemical FormulaC9H6F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 31 structure
31
氟苯丙胺杂质31Fenfluramine Impurity 31
Fenfluramine Impurity 31
CAS No.2338-75-2
Chemical FormulaC9H6F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 32 structure
32
氟苯丙胺杂质32Fenfluramine Impurity 32
Fenfluramine Impurity 32
CAS No.22902-93-8
Chemical FormulaC9H8F3NO
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 33 structure
33
氟苯丙胺杂质33Fenfluramine Impurity 33
Fenfluramine Impurity 33
CAS No.401-79-6
Chemical FormulaC8H7F3
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 36 structure
36
氟苯丙胺杂质36Fenfluramine Impurity 36
Fenfluramine Impurity 36
CAS No.2101305-71-7
Chemical FormulaC10H11F3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 36 Sodium Salt structure
36
氟苯丙胺杂质36 钠盐Fenfluramine Impurity 36 Sodium Salt
Fenfluramine Impurity 36 Sodium Salt
CAS No.2101305-72-8
Chemical FormulaC10H10F3O4S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 43 structure
43
氟苯丙胺杂质43Fenfluramine Impurity 43
Fenfluramine Impurity 43
CAS No.61471-62-3
Chemical FormulaC11H14F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 44 structure
44
氟苯丙胺杂质44Fenfluramine Impurity 44
Fenfluramine Impurity 44
CAS No.51353-04-9
Chemical FormulaC13H18F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 45 structure
45
氟苯丙胺杂质45Fenfluramine Impurity 45
Fenfluramine Impurity 45
CAS No.90754-95-3
Chemical FormulaC12H16F3N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 57 structure
57
氟苯丙胺杂质57Fenfluramine Impurity 57
Fenfluramine Impurity 57
CAS No.71792-93-3
Chemical FormulaC17H12F6O
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 58 structure
58
氟苯丙胺杂质58Fenfluramine Impurity 58
Fenfluramine Impurity 58
CAS No.14355-04-5
Chemical FormulaC10H12F3N
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 61 structure
61
氟苯丙胺杂质61Fenfluramine Impurity 61
Fenfluramine Impurity 61
CAS No.329-15-7
Chemical FormulaC8H4ClF3O
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 62 Iodide structure
62
氟苯丙胺杂质62 碘化物Fenfluramine Impurity 62 Iodide
Fenfluramine Impurity 62 Iodide
CAS No.2770278-13-0
Chemical FormulaC9H11F3N+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Fenfluramine Impurity 62 structure
62
氟苯丙胺杂质62Fenfluramine Impurity 62
Fenfluramine Impurity 62
CAS No.775-00-8
Chemical FormulaC9H10F3N
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

氟苯丙胺 —— 研究文献与合成路线Fenfluramine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 氟苯丙胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Fenfluramine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine
    Salsbury JS, Isbester PK · Magnetic resonance in chemistry : MRC · 2005 · 被引 15cited 15

合成与制备工艺专利Synthesis & process patents

  1. Fenfluramine hydrochloride drop pills and its preparation method
    QIAN JIN, XU JUN, PENG HONG · 公开号 CN1602845CN1602845 · 2005
  2. Fenfluramine hydrochloride raw material drug and its preparing method
    PU YIHUA, SUN GUOJIAN, YU FENG · 公开号 CN1634857CN1634857 · 2005
  3. Process for manufacturing 1-(3-trifluoromethyl)phenyl-propan-2-one intermediate in the synthesis of the fenfluramine
    CANNATA VINCENZO, GALBIATI BARBARA, SPREAFICO ANGELO · 公开号 EP0810195EP0810195 · 1997
  4. Process for preparing levo and dextro fenfluramine
    Magnone Grato · 公开号 EP0441160EP0441160 · 1991
  5. The use of D-Fenfluramine for the manufacture of medicaments for treating depression
    Wurtman Richard J., Wurtman Judith J., O'Rourke Dermot · 公开号 EP0253146EP0253146 · 1988

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

氟苯丙胺 杂质谱研究要点Fenfluramine — impurity profiling notes

下面这些是拿到 氟苯丙胺 的 39 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 39 impurity entries for Fenfluramine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances